KCM
AVDL
Kennedy Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.68M | Buy |
981,271
+227,228
| +30% | +$2.01M | 0.21% | 169 |
|
|
2025
Q1 | $5.9M | Sell |
754,043
-302,891
| -29% | -$2.37M | 0.14% | 252 |
|
|
2024
Q4 | $11.1M | Buy |
1,056,934
+468,757
| +80% | +$4.93M | 0.25% | 121 |
|
|
2024
Q3 | $7.71M | Sell |
588,177
-65,939
| -10% | -$865K | 0.17% | 212 |
|
|
2024
Q2 | $9.2M | Buy |
654,116
+969
| +0.1% | +$13.6K | 0.2% | 173 |
|
|
2024
Q1 | $11M | Buy |
653,147
+7,273
| +1% | +$123K | 0.23% | 150 |
|
|
2023
Q4 | $9.12M | Sell |
645,874
-69,550
| -10% | -$982K | 0.2% | 190 |
|
|
2023
Q3 | $7.37M | Buy |
715,424
+268,704
| +60% | +$2.77M | 0.18% | 208 |
|
|
2023
Q2 | $7.36M | Buy |
446,720
+25,463
| +6% | +$420K | 0.17% | 224 |
|
|
2023
Q1 | $3.86M | Buy |
+421,257
| New | +$3.86M | 0.11% | 303 |
|
|
2016
Q1 | – | Sell |
-521,553
| Closed | -$6.37M | – | 730 |
|
|
2015
Q4 | $6.37M | Sell |
521,553
-892,314
| -63% | -$10.9M | 0.13% | 289 |
|
|
2015
Q3 | $23.1M | Sell |
1,413,867
-302,563
| -18% | -$4.93M | 0.47% | 27 |
|
|
2015
Q2 | $36.4M | Buy |
1,716,430
+272,400
| +19% | +$5.77M | 0.65% | 2 |
|
|
2015
Q1 | $26M | Buy |
1,444,030
+236,620
| +20% | +$4.25M | 0.45% | 31 |
|
|
2014
Q4 | $20.7M | Buy |
1,207,410
+175,172
| +17% | +$3M | 0.38% | 42 |
|
|
2014
Q3 | $14.8M | Buy |
1,032,238
+307,628
| +42% | +$4.4M | 0.29% | 77 |
|
|
2014
Q2 | $10.9M | Buy |
724,610
+277,114
| +62% | +$4.16M | 0.2% | 169 |
|
|
2014
Q1 | $6M | Buy |
+447,496
| New | +$6M | 0.11% | 333 |
|